Mohs micrographic surgery for the treatment of primary cutaneous mucinous carcinoma
Open Access
- 14 February 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 48 (7) , 778-780
Abstract
Primary cutaneous mucinous carcinoma (PCMC) is a rare adnexal tumour of the skin. Clinically, it appears as a benign cyst, but it has characteristic histopathology. It is a slow-growing tumour that rarely metastasizes but is associated with significant morbidity due to its high recurrence rate. Standard practice has been to surgically remove it with a wide local excision of 1–2-cm margin. In the last decade, increasing reports of Mohs micrographic surgery (MMS) for the treatment of PCMC have been described. MMS appears to reduce recurrence rates while allowing for more conservative margins. Given the rarity of PCMC, there are no prospective randomized control trials on treatment. This is the largest case series of PCMC treated by MMS to date.Keywords
This publication has 8 references indexed in Scilit:
- Analysis of Head and Neck Primary Cutaneous Mucinous Carcinoma: An Indolent Tumor of the Eccrine Sweat GlandsJournal of Craniofacial Surgery, 2020
- Prognostic Factors, Treatment, and Survival in Primary Cutaneous Mucinous Carcinoma: A SEER Database AnalysisDermatologic Surgery, 2019
- Bilateral Primary Mucinous Carcinoma of the EyelidOphthalmic Plastic & Reconstructive Surgery, 2017
- Primary Mucinous Carcinoma of the SkinDermatologic Surgery, 2015
- Primary Cutaneous Mucinous CarcinomaJAMA Dermatology, 2014
- Primary Mucinous Carcinoma of the EyelidArchives of Ophthalmology (1950), 2010
- Primary cutaneous mucinous carcinoma: Report of two cases treated with Mohs’ micrographic surgeryAustralasian Journal of Dermatology, 2006
- Mucinous sweat gland adenocarcinoma of eyelid.A clinicopathologic study of 21 cases with histochemical and electron microscopic observationsCancer, 1979